What named patient supply means
Named patient supply, also called special access or compassionate supply, is a route for a medicine that is not registered in a country to reach a specific patient. The request normally comes from the treating practitioner or a licensed healthcare institution, and the regulator sets the conditions.
The three examples below show how much the details vary, so always check the rules of your own country.
Canada: Special Access Program
- Health Canada's Special Access Program lets practitioners request a drug that is unavailable for sale in Canada.
- Most often the practitioner using the programme is a licensed physician.
- It is intended for patients with serious or life-threatening conditions where conventional treatments have failed, are unsuitable or are unavailable.
Singapore: Special Access Routes
- The Health Sciences Authority allows unregistered therapeutic products to be imported for patients through its special access routes.
- Applications can come from a licensed hospital, clinic or nursing home, from a retail pharmacy with a valid prescription from a registered doctor or dentist, or from a company acting on behalf of a licensed hospital, clinic or nursing home.
- HSA says unregistered products should only be considered for life-saving therapies, and approval is needed for each consignment before import.
- The importer needs an importer's licence and a wholesaler's licence from HSA before importing, and the requesting doctor or dentist is fully responsible for the use of the product.
New Zealand: section 29 of the Medicines Act 1981
- Section 29 permits the supply of unapproved medicines to medical practitioners, nurse practitioners and pharmacist prescribers.
- Supply is for the treatment of a named patient under their care.
- Suppliers notify Medsafe after the end of every month in which the medicine was supplied.
What these routes have in common
- One patient at a time. Supply is linked to an individual patient and a responsible practitioner or institution.
- The regulator decides. An approval, a notification or both may be needed, sometimes for each consignment.
- Licensed importers. The organisation bringing the medicine into the country may need its own licences.
What to have ready
- The medicine: INN or brand, strength, dosage form and pack size
- The quantity needed for the patient
- The destination country and the importing organisation
- Any approval or reference your regulator has issued
We supply medicines for named patients where the destination country's rules allow it. See Named Patient Supply or send your enquiry.
Sources
- Health Canada, Special Access Program for drugs: canada.ca
- Health Sciences Authority, Singapore, import for patients (special access routes): hsa.gov.sg
- Medsafe, New Zealand, use of unapproved medicines: medsafe.govt.nz